Novocure partners with Verastem Oncology on pancreatic cancer trial

VSTM•2026-10-28

Novocure and Verastem Oncology will evaluate a combination treatment for locally advanced pancreatic cancer in a trial expected to enroll about 25 patients beginning in 2027.

Novocure partners with Verastem Oncology on pancreatic cancer trial

1. Trial collaboration

2. Company roles

Related News

Comscore expands Magnite partnership to bring predictive audiences to SpringServe

Ares and Apollo embrace new private-credit alchemy

Amazon unveils its newest lineup of Alexa devices

Researchers warn of surging law firm cyber attacks fueled by AI

Kratos wins $33.6 million contract for NASA spacecraft power system